EP2010126A2 - Produit de blanchiment dentaire - Google Patents
Produit de blanchiment dentaireInfo
- Publication number
- EP2010126A2 EP2010126A2 EP07724239A EP07724239A EP2010126A2 EP 2010126 A2 EP2010126 A2 EP 2010126A2 EP 07724239 A EP07724239 A EP 07724239A EP 07724239 A EP07724239 A EP 07724239A EP 2010126 A2 EP2010126 A2 EP 2010126A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- bleaching agent
- agent according
- tooth
- tooth bleaching
- apatite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000007852 tooth bleaching agent Substances 0.000 title claims abstract description 24
- 239000007844 bleaching agent Substances 0.000 claims abstract description 31
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims abstract description 31
- 238000004061 bleaching Methods 0.000 claims abstract description 28
- 229910052586 apatite Inorganic materials 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 23
- 229910052587 fluorapatite Inorganic materials 0.000 claims abstract description 17
- 239000002245 particle Substances 0.000 claims abstract description 16
- 230000002087 whitening effect Effects 0.000 claims description 17
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 14
- -1 alkaline earth metal salts Chemical class 0.000 claims description 14
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- 239000012190 activator Substances 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 8
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 8
- 150000001768 cations Chemical class 0.000 claims description 8
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 8
- 150000001450 anions Chemical group 0.000 claims description 6
- 229960001922 sodium perborate Drugs 0.000 claims description 6
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- JZBWUTVDIDNCMW-UHFFFAOYSA-L dipotassium;oxido sulfate Chemical compound [K+].[K+].[O-]OS([O-])(=O)=O JZBWUTVDIDNCMW-UHFFFAOYSA-L 0.000 claims description 4
- 239000011572 manganese Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 3
- 239000000080 wetting agent Substances 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 2
- 125000005595 acetylacetonate group Chemical group 0.000 claims description 2
- 230000000975 bioactive effect Effects 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000003975 dentin desensitizing agent Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 229910052748 manganese Inorganic materials 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 1
- 229940050410 gluconate Drugs 0.000 claims 1
- 125000005608 naphthenic acid group Chemical class 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 229940077441 fluorapatite Drugs 0.000 abstract description 10
- 230000000395 remineralizing effect Effects 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 40
- 239000000463 material Substances 0.000 description 18
- 239000011575 calcium Substances 0.000 description 13
- 239000002562 thickening agent Substances 0.000 description 11
- 239000000499 gel Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 7
- 210000003298 dental enamel Anatomy 0.000 description 7
- 229940091249 fluoride supplement Drugs 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000002707 nanocrystalline material Substances 0.000 description 6
- 150000002978 peroxides Chemical class 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 210000004268 dentin Anatomy 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 150000002222 fluorine compounds Chemical class 0.000 description 4
- 229910021485 fumed silica Inorganic materials 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000004530 micro-emulsion Substances 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- 101000623895 Bos taurus Mucin-15 Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 244000303965 Cyamopsis psoralioides Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 2
- 229910001634 calcium fluoride Inorganic materials 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- VPUGDVKSAQVFFS-UHFFFAOYSA-N coronene Chemical compound C1=C(C2=C34)C=CC3=CC=C(C=C3)C4=C4C3=CC=C(C=C3)C4=C2C3=C1 VPUGDVKSAQVFFS-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000003578 releasing effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- BYOBJKVGOIXVED-UHFFFAOYSA-N (2-phosphonoazepan-2-yl)phosphonic acid Chemical compound OP(O)(=O)C1(P(O)(O)=O)CCCCCN1 BYOBJKVGOIXVED-UHFFFAOYSA-N 0.000 description 1
- QAQSNXHKHKONNS-UHFFFAOYSA-N 1-ethyl-2-hydroxy-4-methyl-6-oxopyridine-3-carboxamide Chemical compound CCN1C(O)=C(C(N)=O)C(C)=CC1=O QAQSNXHKHKONNS-UHFFFAOYSA-N 0.000 description 1
- OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 description 1
- HNNQYHFROJDYHQ-UHFFFAOYSA-N 3-(4-ethylcyclohexyl)propanoic acid 3-(3-ethylcyclopentyl)propanoic acid Chemical class CCC1CCC(CCC(O)=O)C1.CCC1CCC(CCC(O)=O)CC1 HNNQYHFROJDYHQ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- RAFGELQLHMBRHD-VFYVRILKSA-N Bixin Natural products COC(=O)C=CC(=C/C=C/C(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)/C)C RAFGELQLHMBRHD-VFYVRILKSA-N 0.000 description 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241001286462 Caio Species 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010041308 Endothelial Growth Factors Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- SNVFDPHQAOXWJZ-UHFFFAOYSA-N Furcelleran Chemical compound CCOC(=O)C1=C(C)NC(C=2C=CC=CC=2)=C(C(=O)OCC=2C=CC=CC=2)C1C#CC1=CC=CC=C1 SNVFDPHQAOXWJZ-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000950638 Symphysodon discus Species 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241001541238 Vachellia tortilis subsp. raddiana Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- RAFGELQLHMBRHD-UHFFFAOYSA-N alpha-Fuc-(1-2)-beta-Gal-(1-3)-(beta-GlcNAc-(1-6))-GalNAc-ol Natural products COC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC(O)=O RAFGELQLHMBRHD-UHFFFAOYSA-N 0.000 description 1
- 150000004645 aluminates Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000001670 anatto Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 235000012665 annatto Nutrition 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UDEWPOVQBGFNGE-UHFFFAOYSA-N benzoic acid n-propyl ester Natural products CCCOC(=O)C1=CC=CC=C1 UDEWPOVQBGFNGE-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- RAFGELQLHMBRHD-SLEZCNMESA-N bixin Chemical compound COC(=O)\C=C\C(\C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O RAFGELQLHMBRHD-SLEZCNMESA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940112869 bone morphogenetic protein Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 229910000394 calcium triphosphate Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 229910052589 chlorapatite Inorganic materials 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960003185 chlortetracycline hydrochloride Drugs 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003479 dental cement Substances 0.000 description 1
- 239000005548 dental material Substances 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- BHDAXLOEFWJKTL-UHFFFAOYSA-L dipotassium;carboxylatooxy carbonate Chemical compound [K+].[K+].[O-]C(=O)OOC([O-])=O BHDAXLOEFWJKTL-UHFFFAOYSA-L 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical class CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 238000004334 fluoridation Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000002173 high-resolution transmission electron microscopy Methods 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229960004995 magnesium peroxide Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- OLXYLDUSSBULGU-UHFFFAOYSA-N methyl pyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC=C1 OLXYLDUSSBULGU-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- RFWLACFDYFIVMC-UHFFFAOYSA-D pentacalcium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O RFWLACFDYFIVMC-UHFFFAOYSA-D 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229910052585 phosphate mineral Inorganic materials 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- VKJKEPKFPUWCAS-UHFFFAOYSA-M potassium chlorate Chemical compound [K+].[O-]Cl(=O)=O VKJKEPKFPUWCAS-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000000550 scanning electron microscopy energy dispersive X-ray spectroscopy Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- 150000003438 strontium compounds Chemical class 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000012756 surface treatment agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- QUBMWJKTLKIJNN-UHFFFAOYSA-B tin(4+);tetraphosphate Chemical compound [Sn+4].[Sn+4].[Sn+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QUBMWJKTLKIJNN-UHFFFAOYSA-B 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/65—Dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/838—Phosphorus compounds, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/651—The particulate/core comprising inorganic material
Definitions
- the dental bleaching agent of the present invention includes apatite, more preferably in nano-sized particle sizes, also more preferably as fluoroapatite Remineralization of the tooth surface act.
- the discoloration of teeth may be due to the natural aging process, the use of certain foods and tobacco, diseases, injuries, medicines and innate and environmental conditions. Since white or light teeth are generally more aesthetic than dark or discolored teeth, there has always been much interest in the development of teeth whitening materials and methods.
- Some dentifrices such as toothpastes, gels and powders contain active oxygen or hydrogen peroxide-releasing bleaching materials.
- Such bleaches contain peroxides, percarbonates and perborates of alkali and Alkaline earth metals or complex compounds containing hydrogen peroxide.
- percarbamide also called urea peroxohydrate or urea - hydrogen peroxide.
- Percarbamide has been used in dentistry for decades as an oral antiseptic. Urea itself is described in the literature as a keratinizing agent for the gums. Tooth whitening was an observed side effect with extended contact times.
- Other bleaching agents such as. As peroxyacetic acid and sodium perborate, are also well known in the medical, dental and cosmetic field.
- bleaching gels The bleaching gels on the market, known worldwide as “bleaching gels", are divided into three categories (Reality Report VoI .14 / 2000), namely "Power Bleaching”, “Assisted Bleaching” and “Home Bleaching". To save time and money, "dental bleaching" in the dental office is the preferred method for bleaching discolored teeth.
- Sodium monofluorophosphate, sodium fluoride and zinc fluoride, antimicrobial agents such as chlorhexidine, tetracycline, cetylpyridinium chloride, benzalkonium chloride, cetylpyridinium bromide, methyl benzoate and propyl benzoate.
- Discus Dental offers bleach with additions of amorphous calcium triphosphate. Their advantage lies in the addition which is in principle suitable for remineralization during the bleaching process. In slightly acidic conditions, where o.g. Bleaches are generally more stable, but these are not stable. They also contain no fluoride.
- a remineralizing dental adhesive film which consists of a carrier material adhering to the tooth and active ingredients incorporated therein.
- the active substances consist of hydroxyapatite, fluorapatite, calcium fluoride and di-tri- or tetracalcium phosphate.
- An important object of the present invention was to provide a new and improved single or multi-component whitening bleach for teeth desensitizing, fluoride-releasing and remineralizing properties.
- a dental bleaching agent which comprises an apatite of the general composition
- M is a cation other than Ca 2+
- B is an anion other than PO 4 3 "
- the apatite is characterized by more than 50% by weight.
- the apatite particles have a particle size in the range of ⁇ 500 nm, more preferably in the range of ⁇ 200 nm, and most preferably in the range of ⁇ 100 nm.
- the tooth whitening agent of this invention contains at least one orally compatible bleaching agent.
- Various bleaching agents and / or bleaching mixtures can be used for the preparation of the tooth whitening agent, such as hydrogen peroxide, percarbamide, sodium perborate, potassium peroxomonosulfate, potassium chlorate, potassium percarbonate, Sodium percarbonate, calcium peroxide, magnesium peroxide, perphosphates, persilicates, benzoyl peroxide, glycerol peroxide, calcium hydrogencarbonate peroxide and
- Hydrogen peroxide, percarbamide, sodium perborate and potassium peroxomonosulfate are preferred. Hydrogen peroxide, percarbamide, sodium perborate and / or potassium peroxomonosulfate and / or mixtures thereof are present in the total dental bleaching agent, preferably in an amount of 5-70% by weight, preferably in an amount of 5-55% by weight.
- the content of the bleaching agent in the whole dental bleaching agent may be 5-75% by weight, preferably 5-60% by weight, more preferably 10-30% by weight, still more preferably 15-25% by weight.
- the tooth whitening agent of this invention may contain one or more activator components.
- the activator component may be a gel, e.g., an alkaline gel. It preferably contains one or more alkali and / or alkaline earth metal salts. As activators or
- decomposition catalysts for salts or complexes from the group of copper, manganese and / or iron, very particularly preferably organometallic complexes or salts, for example acetylacetonates, gluconates, lactates, fumarates, naphthenic acid salts, metallocenes, oxalates, citrates, sulfates, oxides, Acetates and / or mixtures thereof. They show violent to mild reactions in the decomposition of peroxides according to their chemical character.
- the Activator component may additionally contain another peroxide.
- the content of the activator component in the whole dental bleaching agent may be 0.1-30% by weight, preferably 0.2-20% by weight, more preferably 0.5-10% by weight.
- the bleach and / or the optional activator component may contain gelling agents or thickeners.
- gelling agents or thickeners examples are cellulose polymers, polycarboxylic acids, fumed silica, poly (meth) acrylic acids, polysaccharides, polyvinyl butyrals, alginates, coumarone resins, shellac, xanthan, tragacanth, guar, carrageenan, alginic acids, etc., and / or mixtures thereof. They may be present together in an amount of 0.01-20% by weight, preferably in an amount of 0.05-15% by weight.
- Water or water in combination with other bases is often used as a base material for the production of stable dental bleaching agents.
- bases include or consist of polyols such as polyethylene glycol, sorbitol, polypropylene glycol, propylene glycol, glycerol, ethanol, acetone, ethers, acetic acid esters, xylitol and others and / or mixtures of the foregoing.
- Polyols such as glycerol and / or propylene glycol and / or demineralized water are preferred in this invention. They are present either alone or as mixtures and are present in an amount of 0.1-98 weight percent, and preferably in an amount of 0.5-95 weight percent based on the total tooth whitening agent.
- B. stabilizers such as alkali metal polyphosphates, Alkali metal pyrophosphates, ethylenediaminetetraacetic acid and its salts, tartaric acid and its salts, citric acid and its salts, gluconic acid and its salts, triethanolamine, stannous nitrate, adipic acid, tin phosphate, succinic acid, etc., such as pH change components such as alkali and alkaline earth metal salts such as vitamins as anti-inflammatory agents as well as flavorings such as peppermint, vanillin, etc., colorants for coloring and as indicators, preservatives, fluoride derivatives, wetting agents, etc. They may be present either alone or in mixtures in the bleaches of this invention.
- the bleaching agents may also be activated by exposure to heat (mouth temperature, hot light, laser, or possibly other sources) in addition to or instead of one or more activators, optionally supported by additions of energy-absorbing substances, e.g. Carotenoids, coronene, bixin, perylene, flavins etc.
- heat mouth temperature, hot light, laser, or possibly other sources
- energy-absorbing substances e.g. Carotenoids, coronene, bixin, perylene, flavins etc.
- apatites provide an important basis for the incorporation of calcium into hard tooth substances (e.g., enamel, dentin, bone) and that they play an important role in healthy teeth, when combined with other phosphate and non-phosphate minerals.
- hard tooth substances e.g., enamel, dentin, bone
- the best known representative of this class of substances is the hydroxyapatite with stoichiometric formula Cai 0 (PO 4 ) 6 (OH) 2 or Ca 5 (PO 4 ) 3 0H.
- Cai 0 (PO 4 ) 6 (OH) 2 or Ca 5 (PO 4 ) 3 0H In its synthetic and biocompatible appearance, it is used in many applications in dentistry, orthopedics and maxillofacial surgery, never occurring in its pure form in biological tissues. This is a consequence of the possible isomorphic exchange of the Ca 2+ , PO 4 3 " and OH " ions, respectively.
- the Ca 2+ -IOn can be produced by a number of (mostly divalent) cations.
- the phosphate anion can be replaced by carbonate, hydrogen phosphate, pyrophosphate, sulfate, aluminate and silicate anions; on the other hand, the hydroxide ion can be replaced by halide, carbonate and oxide ions.
- hydroxyapatite is the one most used for the production of materials for orthodontics or for biometric applications.
- Particularly suitable exchange cations are: Na + , K + , Mg 2+ , Ca 2+ , Sr 2+ , Ba 2+ , Y 2+ , Ti 2+ , Zr 2+ , Mn 2+ , Fe 2+ , Pd 2+ , Cu 2+ , Ag + , Zn 2+ , Sn 2+ , Re 2+ , Re 3+ , Al 3+ In 3+ and / or Y 3+ .
- calcium can be replaced by strontium up to about 30% without altering the crystal structure.
- strontium up to about 30% without altering the crystal structure.
- the presence of this element in apatites, which are used in the dental field, is of importance against the background of a possible caries-inhibiting effect as well as a decreased dentin sensitivity. Furthermore, the solubility is lowered. Furthermore, it has been found within the scope of the invention that when certain cations are incorporated into apatites, an antimicrobial effect can be achieved. Particularly useful in this context is the incorporation of Cu 2+ , Ag 2+ , Zn 2+ , and / or Sn 2+ .
- Anions can also act as exchange ions.
- CO 3 2 " , HPO 4 2" , HCO 3 " and P 2 O 7 4" are to be mentioned as B anion, the y value is usually 0-2.
- the hydroxide ions are replaced by fluoride or chloride ions.
- the fluorapatite is characterized by an increase in crystal dimensions and a decrease in the parameters of the unit cell. Furthermore, its solubility is lower and its thermal stability greater, which is why it is used in the treatment of bone diseases or dental caries.
- the cell parameter a of the unit cell is increased or the cell parameter c is reduced in the case of chlorapatite.
- the different crystal lattice is a consequence of the different ionic radii of the fluoride or chloride.
- Fluorapatite is particularly interesting. Because of its lower solubility in the weakly acidic region, fluoridation of the tooth surfaces, ie, conversion of hydroxyapatite into fluoroapatite on the surface of the tooth, can lead to less acid attackable teeth, thus becoming more caries resistant. The presence of fluoroapatite on the tooth surface provides the opportunity for ion exchange between the hydroxylapatite of the tooth surface and the fluoroapatite during the bleaching time. The tooth surface is thus cleaned oxidatively and at the same time made more acid-resistant.
- the bleaching agent for use in a dental bleaching agent usually has a slightly acidic pH to ensure the stability of the bleaching agent such as a peroxide, the enamel is easily etched during bleaching.
- the simultaneous presence of the apatite surprisingly leads directly, ie in situ, during bleaching to a repair of the attacked enamel. Since the specific surface of nano-particles is particularly large, the remineralizing effect of nano-apatites can be orders of magnitude stronger.
- the nano-apatites preferably consisting of nanoparticles or comprising these can be prepared by the methods customarily used for the production of nanocrystalline materials, eg.
- atomic-based methods chemical or physical vapor deposition "vapor deposition", condensation in the gas phase, reactions from aerosols or
- conventional methods mechanical abrasion, crystallization from the amorphous phase, phase separation.
- the precipitation method is a conventional method of producing very fine powder or colloidal suspensions which are successful in the synthesis of clusters used in the nano area, z. B. in the SoI gel technique.
- Nanocrystalline materials are generally man-made materials characterized by continuous phases or by granular structures and usually less than 200 nm in length. Depending on the number of dimensions in which these materials have a nanostructure, a distinction is made between (i) zero-dimensional (atomic clusters, eg dispersed in a matrix of non-nanocrystalline material, filaments, tubules), (ii) one-dimensional (monomolecular layers nanodimensioned only in terms of layer thickness), (iii) two-dimensional (granular superpositions, "granular superpositions", ultra fine layers) and (iv) three-dimensional (in all three dimensions nanoscale structures) materials (RW Siegel, in Materials Science and Technology, Vol. 15: Processing of Metals and Alloys, RW Chan, 583 (1991)).
- zero-dimensional atomic clusters, eg dispersed in a matrix of non-nanocrystalline material, filaments, tubules
- one-dimensional monomolecular layers nanodimensioned only in terms of layer thickness
- the specific properties of the nanocrystalline materials result from three fundamental features, namely (i) the atomic size range of ⁇ 200 nm, (ii) the high proportion of atoms involved in the interfaces, and (iii) the interactions between the individual subregions.
- nanoapatites particularly suitable for bleaching additive addition of the invention: the interactions of crystalline nanoapatite in a bleach formulation with its biological environment can be far more intense than with conventional apatite.
- the particle size of the apatites to be used in the dental material according to the invention is not critical over the ranges indicated. In preferred embodiments, they are characterized in that the particle size of Apatitteilchen to more than 50 wt .-%, optionally more than 60 wt .-% or even more than 70 wt .-% in the range ⁇ 500 nm, more preferably more than 50 wt .-%, optionally to more than 60 wt .-% or even more than 70 wt .-% in the range ⁇ 200 nm, and most preferably to more than 50 wt .-%, optionally to more than 60 wt .-% or even more than 70 wt% in the range ⁇ 100 nm. In a preferred embodiment of the invention, the apatite particles are surface-treated to achieve better dispersivity.
- the Apatit sleepllstoffe may be surface-treated with esters of phosphoric, phosphonic or carboxylic acids.
- esters of mono-di- and triphosphonic acids such as e.g. Tris (phosphonomethyl) amine, azacycloheptane-2, 2-diphosphonic acid, hydroxyethane-1, 1-diphosphonic acid.
- treatments with phosphate salts can be beneficial.
- Another method is to apply a layer of SiO 2 or ZrO 2 on the nanometer scale and subsequent treatment with a functional silane such as hydroxy, amino, alkylorganosilanes.
- the apatites are present in the bleaching material in an amount sufficient to allow ion exchange with the biological environment. Preference is given to proportions by weight of from 1 to 20% by weight, more preferably from 2 to 10%, based on the total weight of the bleaching material.
- the bleaching material may contain additives of optional, but nevertheless very advantageous and no less preferred desensitizing agents, which also have the desensitizing and remineralizing effects in bleaches such as fluorides (sodium monofluorophosphate, sodium fluoride, calcium fluoride, etc.), nitrates (sodium nitrate, potassium nitrate, etc.), strontium compounds (eg, strontium chloride, etc.).
- fluorides sodium monofluorophosphate, sodium fluoride, calcium fluoride, etc.
- nitrates sodium nitrate, potassium nitrate, etc.
- strontium compounds eg, strontium chloride, etc.
- bioactive or antibiotic substances may be added without any limitation, e.g. Transforming Growth Factor Beta, Cell Attachment Factors, Endothelial Growth Factors, Bone Morphogenetic Proteins, Penicillin, Chlortetracycline Hydrochloride, Chloramphenicol, Oxytetracycline, etc.
- wetting agents may also be present in the tooth whitening agent according to the invention as further additives. Preference is given here to the use of sodium lauryl sulfate.
- the bleaching agents according to the invention can be used very well for whitening teeth because of their excellent remineralizing and desensitizing properties.
- the apatite portion of the tooth bleaching formulation may deliver ions to the tooth to be bleached (including fluoride, phosphate, calcium).
- the retention of nanocrystals in interstitial clefts of the enamel or dentin can provide a remineralizing effect beyond the bleaching process.
- the effect envisaged according to the invention namely whitening of the teeth with simultaneous repair of minor lesions by exchange of ions with the tooth substance and, especially when using nano-fluorapatite, the "hardening" of enamel by fluoride exchange is achieved by the tooth bleaching formulations according to the invention.
- the apatite additive of the invention can be used in typical dental bleaching formulations such as glycerol as a base material, pyrogenic silica as a thickener, percarbamide as a bleaching agent.
- Nanocrystalline fluoroapatite was crystallized from a ternary microemulsion.
- an aqueous phase containing CaCl 2 (Merk, Darmstadt, Germany) was emulsified in a mixture of Empilan KB6ZA (ethoxylated lauryl alcohol, Albright's Wilson, Meuse, France) and octane (Sigma-Aldrich, Schnelldorf, Germany) in a fixed ratio of 3: 7 ,
- the microemulsion was stirred at 30 0 C with 30 (I), 36.36 (II) and 50 (III) wt.% 1.0 mol CaCl 2 vigorously, to obtain a micro emulsion.
- the SEM-EDX data (Energy Dispersive X-ray spectrometry) of the powder show sufficiently good agreement with calcium fluorapatite, cf. also figures.
- nanoapatite powder from Example 1 (I) 100 g is slurried in acetone and mixed with 6 g of hydroxyethyl phosphoric ester with constant stirring. After stirring for 2 h, centrifuging off and washing three times with acetone, it was dried.
- One-component gels The basic material used was glycerol and the thickener fumed silica.
- the bleaching formulations prepared were used for whitening enamel and dentin.
- the basic material used was glycerol and the thickener fumed silica.
- Component II Glycerol 93.00% w / w
- Component I Glycerol 74.00% w / w
- Component II Glycerol 93.00% w / w
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006017814 | 2006-04-13 | ||
| PCT/EP2007/003301 WO2007118689A2 (fr) | 2006-04-13 | 2007-04-13 | Produit de blanchiment dentaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2010126A2 true EP2010126A2 (fr) | 2009-01-07 |
Family
ID=38510367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07724239A Withdrawn EP2010126A2 (fr) | 2006-04-13 | 2007-04-13 | Produit de blanchiment dentaire |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20090175917A1 (fr) |
| EP (1) | EP2010126A2 (fr) |
| WO (1) | WO2007118689A2 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009133525A2 (fr) * | 2008-04-29 | 2009-11-05 | High Tech Laser | Composition pour blanchiment des dents |
| WO2011050369A1 (fr) * | 2009-10-23 | 2011-04-28 | Cao Group, Inc. | Compositions de vernis thérapeutique pour la surface des dents |
| US9642687B2 (en) | 2010-06-15 | 2017-05-09 | The Procter & Gamble Company | Methods for whitening teeth |
| US20120244491A1 (en) * | 2011-03-22 | 2012-09-27 | Remigio Piergallini | Device and method for teeth brightening |
| GB201202341D0 (en) * | 2012-02-10 | 2012-03-28 | Periproducts Ltd | Multicomponent oral care compostion |
| US20150238399A1 (en) * | 2012-08-13 | 2015-08-27 | Matthew Scott Spaid | Tooth whitening composition |
| DE102013109758B4 (de) * | 2013-09-06 | 2017-07-13 | Ferton Holding S.A. | Pulvergemisch, Verwendung des Pulvergemischs, Pulverstrahlgerät und Verfahren zur Remineralisierung von Zähnen |
| EP2853622B1 (fr) * | 2013-09-30 | 2016-01-13 | Universidade de Vigo | Procédé d'obtention de nanocristaux de fluorapatite à facettes |
| US9561162B1 (en) * | 2015-08-11 | 2017-02-07 | Okey Okechukwu | Combined dental whitening, polishing, and re-mineralizing system |
| CN109689165B (zh) * | 2016-08-11 | 2022-08-26 | 高露洁-棕榄公司 | 针对顽渍的过一硫酸盐牙粉组合物 |
| CN110799248B (zh) | 2017-06-19 | 2023-06-16 | 高露洁-棕榄公司 | 口腔护理产品及其美白组合物 |
| US10716741B1 (en) | 2018-12-26 | 2020-07-21 | Colgate-Palmolive Company | Oral care compositions and methods for the same |
| US12214063B2 (en) | 2021-02-19 | 2025-02-04 | Colgate-Palmolive Company | Peroxymonosulfate whitening strips |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5098303A (en) * | 1990-03-22 | 1992-03-24 | Ultradent Products, Inc. | Method for bleaching teeth |
| US5376006A (en) * | 1990-03-22 | 1994-12-27 | Ultradent Products, Inc. | Dental bleaching compositions and methods for bleaching teeth surfaces |
| US6036943A (en) * | 1990-03-22 | 2000-03-14 | Ultradent Products, Inc. | Methods for treating a person's teeth using sticky dental compositions in combination with passive-type dental trays |
| US5985249A (en) * | 1990-03-22 | 1999-11-16 | Ultradent Products, Inc. | Sticky dental compositions for adhering a passive-type dental tray over a person's teeth |
| US5234342A (en) * | 1990-03-22 | 1993-08-10 | Ultradent Products, Inc. | Sustained release method for treating teeth surfaces |
| JP3340265B2 (ja) * | 1994-11-21 | 2002-11-05 | 一枝 山岸 | 歯の漂白剤 |
| US5858332A (en) * | 1997-01-10 | 1999-01-12 | Ultradent Products, Inc. | Dental bleaching compositions with high concentrations of hydrogen peroxide |
| US5785527A (en) * | 1997-01-10 | 1998-07-28 | Ultradent Products, Inc. | Stable light or heat activated dental bleaching compositions |
| JP2001233749A (ja) * | 2000-02-28 | 2001-08-28 | Kazue Yamagishi | 歯牙美白用組成物 |
| ES2320321T3 (es) * | 2000-03-17 | 2009-05-21 | LG HOUSEHOLD & HEALTH CARE LTD. | Parches para blanquear dientes. |
| US20050123490A1 (en) * | 2003-12-04 | 2005-06-09 | Kazue Yamagishi | Composition and method for prevention and treatment of dental caries |
| DE102004025030A1 (de) * | 2004-05-18 | 2005-12-15 | S&C Polymer Silicon- und Composite-Spezialitäten GmbH | Nano-Apatit-Füllstoffe enthaltende härtbare Restaurationsmaterialien |
| US9271902B2 (en) * | 2005-02-15 | 2016-03-01 | Martin S. Giniger | Whitening system capable of delivering effective whitening action |
-
2007
- 2007-04-13 EP EP07724239A patent/EP2010126A2/fr not_active Withdrawn
- 2007-04-13 US US12/226,251 patent/US20090175917A1/en not_active Abandoned
- 2007-04-13 WO PCT/EP2007/003301 patent/WO2007118689A2/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2007118689A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007118689A3 (fr) | 2008-12-11 |
| WO2007118689A2 (fr) | 2007-10-25 |
| US20090175917A1 (en) | 2009-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007118689A2 (fr) | Produit de blanchiment dentaire | |
| DE3921133C2 (de) | Wasserstoffperoxid freisetzende Zahnpasta | |
| DE69830992T2 (de) | Desensibilisierende zahnpaste mit beschränkter astringenz | |
| DE69004004T2 (de) | Kolloidales Fluorid und orale Zusammensetzung. | |
| DE69522956T2 (de) | Orale zusammensetzung enthaltend stabilisierte zinn komponente | |
| DE60109207T2 (de) | Orale zusammensetzung | |
| EP1139995B1 (fr) | Suspensions de sels de calcium de fine dispersion et peu solubles dans l'eau et leur utilisation dans des produits d'hygiene dentaire | |
| DE3619867A1 (de) | Zahnpasta mit hydrogenkarbonat | |
| EP0216189A2 (fr) | Composition d'hygiène orale | |
| DE10340542A1 (de) | Mund- und Zahnpflegemittel | |
| CN101489925A (zh) | 用碳酸根置换的羟磷灰石的生物活性纳米粒子及其制备方法和包含其的组合物 | |
| DE102004025030A1 (de) | Nano-Apatit-Füllstoffe enthaltende härtbare Restaurationsmaterialien | |
| DE10340543A1 (de) | Mund- und Zahnpflegemittel | |
| WO2012119155A1 (fr) | Compositions antimicrobiennes pour la fluoruration et la reminéralisation des dents | |
| DE3044448A1 (de) | Zahncreme | |
| DE3786920T2 (de) | Periodontische zusammensetzung und verfahren. | |
| DE3545985A1 (de) | Oral anzuwendendes mittel | |
| EP1572142B1 (fr) | Matieres composites constituees de composes de calcium et de polysaccharides contenant de l'acide glucuronique | |
| EP1824445A1 (fr) | Agents de blanchiment des dents | |
| DE10064637A1 (de) | Nanopartikuläres oberflächenmodifiziertes Titanoxid und seine Verwendung in Zahnpflegemitteln | |
| DE60217857T2 (de) | Remineralisierende zahnhygieneprodukte | |
| WO2008031619A1 (fr) | Fluorures alcalino-terreux nano-cristallin dans des agents de blanchiment dentaire | |
| DE2522042A1 (de) | Zahnpasta | |
| DE102006039632A1 (de) | Zusammensetzung enthaltend schwer wasserlösliche Calciumsalze und/oder deren Kompositmaterialien in einer Menge von 1 bis 99 Gew.-% | |
| DE2400721C2 (fr) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20081113 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
| R17D | Deferred search report published (corrected) |
Effective date: 20081211 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: GOERLICH, KARL-JOACHIM Inventor name: ENGELBRECHT, JUERGEN |
|
| 17Q | First examination report despatched |
Effective date: 20091026 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20100306 |